ABI Research predicts that several anticipated technological advancements will not materialize in 2025. Key technologies such as AI-RAN, consumer smart glasses, humanoids, and semiconductor onshoring are expected to face delays, with large-scale deployments likely pushed to 2026 or 2027. The upcoming year will focus on addressing implementation challenges and refining strategies to enhance customer value and return on investment.
Despite ongoing trials and pilot projects, the widespread adoption of these technologies remains uncertain. For instance, while SoftBank is progressing with AI-RAN trials, significant commercial deployment is not expected until 2026. Similarly, consumer smart glasses will continue to appeal primarily to early adopters, with most traction occurring in niche applications rather than mainstream markets.
• AI-RAN technology will not see widespread deployment until 2026.
• Consumer smart glasses will remain niche products in 2025.
AI-RAN refers to Artificial Intelligence technology for Radio Access Networks, which is still in early development.
Humanoids are robots designed to resemble humans, but they are not ready for widespread use.
S. and Europe, facing significant delays.
ABI Research provides insights on technology trends, identifying what will and won't happen in 2025.
SoftBank is involved in AI-RAN trials, aiming for deployment by 2026.
Isomorphic Labs, the AI drug discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital for the first time. The $600
How to level up your teaching with AI. Discover how to use clones and GPTs in your classroom—personalized AI teaching is the future.
Trump's Third Term? AI already knows how this can be done. A study shows how OpenAI, Grok, DeepSeek & Google outline ways to dismantle U.S. democracy.
Sam Altman today revealed that OpenAI will release an open weight artificial intelligence model in the coming months. "We are excited to release a powerful new open-weight language model with reasoning in the coming months," Altman wrote on X.